Genpact Limited (NYSE:G) has earned a consensus rating of “Buy” from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $33.67.
G has been the subject of a number of recent analyst reports. Zacks Investment Research cut shares of Genpact from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Robert W. Baird restated a “buy” rating and issued a $34.00 price objective on shares of Genpact in a research report on Monday, September 25th. Cantor Fitzgerald restated a “buy” rating and issued a $36.00 price objective on shares of Genpact in a research report on Wednesday, November 8th. BMO Capital Markets restated a “hold” rating on shares of Genpact in a research report on Friday, October 6th. Finally, SunTrust Banks restated a “buy” rating and issued a $34.00 price objective on shares of Genpact in a research report on Monday, October 9th.
In other Genpact news, insider Mohit Thukral sold 25,000 shares of the stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $32.25, for a total transaction of $806,250.00. Following the completion of the transaction, the insider now owns 85,305 shares in the company, valued at approximately $2,751,086.25. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Arvinder Singh sold 22,855 shares of the stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $32.23, for a total value of $736,616.65. Following the transaction, the senior vice president now owns 37,623 shares of the company’s stock, valued at approximately $1,212,589.29. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,675,525 shares of company stock valued at $50,978,024. Corporate insiders own 1.41% of the company’s stock.
Shares of Genpact (G) opened at $34.49 on Tuesday. The company has a market cap of $6,640.00, a price-to-earnings ratio of 24.99, a price-to-earnings-growth ratio of 2.14 and a beta of 0.58. Genpact has a 1 year low of $23.34 and a 1 year high of $34.55. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.77.
Genpact (NYSE:G) last issued its earnings results on Tuesday, November 7th. The business services provider reported $0.46 EPS for the quarter, beating the consensus estimate of $0.36 by $0.10. The company had revenue of $708.82 million during the quarter, compared to analysts’ expectations of $685.25 million. Genpact had a net margin of 10.18% and a return on equity of 23.86%. The business’s revenue for the quarter was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 EPS. equities research analysts forecast that Genpact will post 1.47 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/01/23/genpact-limited-g-receives-consensus-rating-of-buy-from-analysts.html.
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.